RECRUITING

Working Memory Training for People Aging with HIV

Talk to us

Conditions

Cognitive Change

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The present study investigates the feasibility of working memory training in people aging with HIV (PAWHIV). In a cross-over design this stage 1 feasibility trial, will evaluate acceptability, and estimate possible effect sizes related to working memory training by examining potential differential effects in PAWHIV and those aging without HIV. This project highlights the importance of tailored cognitive assessments and interventions, engaging with underrepresented communities to enhance inclusivity in cognitive health research.

Official Title

A Feasibility Study of Working Memory Training for People Aging with HIV

Quick Facts

Study Start:2024-07-15
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06699927

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 50-85 years of age
  2. * Able to understand and speak English and follow study procedures
  3. * Does not have a psychological or neurological condition that would prevent being able to give consent to participate
  4. * Not currently involved in any other cognitive or memory training studies
  1. * Formal diagnosis of dementia or other neurological disease, including Mild cognitive impairment.
  2. * A final total score below 17 on Montreal Cognitive Assessment - Blind (telephone) version.
  3. * Score of 10 or more on the Generalized Anxiety Questionnaire (GAD7; Spitzer et al., 2006, Archives of Internal Medicine), indicating presence of moderate or severe anxiety
  4. * Score of 9 or more on Geriatric depression scale (GDS15; Yesavage et al., 1982) indicating presence of moderate or severe depression
  5. * Abnormal visual acuity prohibitive of tablet-based training.
  6. * Physical handicap (motor or perceptual) that would impede training procedures.
  7. * Medical illness requiring treatment and/or significant absences during the study timeline.
  8. * Current evidence or 2-yr history of seizures, focal brain lesion, or head injury with loss of consciousness.
  9. * Current alcohol consumption exceeds 14 drinks per week.
  10. * Self-reported illicit drug use.

Contacts and Locations

Study Contact

Morgan Gomez
CONTACT
‪(774) 226-9323‬
gomez.mo@northeastern.edu
Audrey Carrillo, MA
CONTACT
a.carrillo@northeastern.edu

Principal Investigator

Susanne Jaeggi, PhD
PRINCIPAL_INVESTIGATOR
Northeastern University
Aaron Seitz
PRINCIPAL_INVESTIGATOR
Northeastern University

Study Locations (Sites)

Northeastern University
Boston, Massachusetts, 02115
United States

Collaborators and Investigators

Sponsor: Northeastern University

  • Susanne Jaeggi, PhD, PRINCIPAL_INVESTIGATOR, Northeastern University
  • Aaron Seitz, PRINCIPAL_INVESTIGATOR, Northeastern University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-15
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2024-07-15
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Cognitive Change